Gossamer Bio Inc.(GOSS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GOSS Gossamer Bio Inc.

休市中 07-31 16:00:00 EDT

0.1695

-0.0088

-4.94%

盘后0.1663

-0.0032-1.89%

19:59 EDT

最高0.1829	最低0.1653	成交量2,562万
今开0.1770	昨收0.1783	日振幅9.87%
总市值8,289万	流通市值5,305万	总股本4.89亿
成交额453.60万	换手率8.18%	流通股本3.13亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GOSS","market":"US","secType":"STK","nameCN":"Gossamer Bio Inc.","latestPrice":0.1695,"timestamp":1785528000000,"preClose":0.1783,"halted":0,"volume":25616398,"hourTrading":{"tag":"盘后","latestPrice":0.1663,"preClose":0.1695,"latestTime":"19:59 EDT","volume":699854,"amount":118293.789144,"timestamp":1785542351969,"change":-0.0032,"changeRate":-0.018879,"amplitude":0.032448},"delay":0,"changeRate":-0.04935501962983722,"floatShares":313000000,"shares":488999999,"eps":-0.783142,"marketStatus":"休市中","change":-0.0088,"latestTime":"07-31 16:00:00 EDT","open":0.177,"high":0.1829,"low":0.1653,"amount":4535998.059452,"amplitude":0.09871,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.783142,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1785744000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1549602000000,"exchange":"NASDAQ","adjPreClose":0.1783,"preHourTrading":{"tag":"盘前","latestPrice":0.1799,"preClose":0.1783,"latestTime":"09:29 EDT","volume":3760890,"amount":734919.651879,"timestamp":1785504559720,"change":0.0016,"changeRate":0.008974,"amplitude":0.298934},"postHourTrading":{"tag":"盘后","latestPrice":0.1663,"preClose":0.1695,"latestTime":"19:59 EDT","volume":699854,"amount":118293.789144,"timestamp":1785542351969,"change":-0.0032,"changeRate":-0.018879,"amplitude":0.032448},"volumeRatio":0.20007603677293873,"impliedVol":0.6236,"impliedVolPercentile":0.4064},"requestUrl":"/m/hq/s/GOSS","defaultTab":"news","newsList":[{"id":"1116851334","title":"Gossamer Bio公布FDA监管进展，重获Seralutinib全球权利并发布业务更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1116851334","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116851334?lang=zh_cn&edition=full","pubTime":"2026-07-27 19:01","pubTimestamp":1785150115,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc.于今日正式对外宣布一项重要监管进展。该公司不仅获得了来自美国食品药品监督管理局的监管更新，还成功重获其核心药物Seralutinib的全球权益。与此同时，企业同步披露了最新的业务动态。\n这一系列举措彰显了Gossamer Bio在管线推进与战略整合上的积极姿态。Seralutinib作为一种潜在的治疗肺动脉高压的新药，其全球权利的重新获取意味着公司在未来研发与商业化布局中将拥有更大的自主权。\n在本次公告中，公司管理层强调，这些进展为后续的临床开发与市场拓展奠定了坚实基础。投资者正密切关注该公司下一步的具体行动方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","GOSS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196490542","title":"Gossamer Bio Inc. 公布2030年到期7.50%可转换优先有担保第一留置权票据转换率及购股权证行权价","url":"https://stock-news.laohu8.com/highlight/detail?id=1196490542","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196490542?lang=zh_cn&edition=full","pubTime":"2026-07-01 21:01","pubTimestamp":1782910874,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc. 已正式确定其2030年到期的7.50%可转换优先有担保第一留置权票据的转换比率，并同时公布了相关购股权证的行权价格。此举标志着公司融资工具关键条款的最终敲定，为投资者提供了明确的转换与行权依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174119316","title":"Gossamer Bio Inc. 公布现有可转换票据交换要约及同意征求最终投标结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1174119316","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174119316?lang=zh_cn&edition=full","pubTime":"2026-06-17 20:00","pubTimestamp":1781697646,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc. 已正式公布其针对现有可转换票据的交换要约及同意征求的最终投标结果。公司确认，相关程序已按计划完成，并取得了预期的参与度。此举是公司优化资本结构、管理债务到期情况的重要步骤。最终结果的公布为市场提供了明确信息，标志着这一财务操作的关键阶段已告结束。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","GOSS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148661807","title":"Gossamer Bio Inc. 宣布延长现有可转换票据交换要约及同意征求的早期投标截止日","url":"https://stock-news.laohu8.com/highlight/detail?id=1148661807","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148661807?lang=zh_cn&edition=full","pubTime":"2026-06-02 20:01","pubTimestamp":1780401689,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc. 宣布，针对其现有可转换票据的交换要约及同意征求，公司已决定将早期投标的截止日期予以延长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102631624","title":"Gossamer Bio Inc. 启动交换要约与征求同意，旨在依托现有票据持有人支持消除超1.2亿美元债务","url":"https://stock-news.laohu8.com/highlight/detail?id=1102631624","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102631624?lang=zh_cn&edition=full","pubTime":"2026-05-18 19:06","pubTimestamp":1779102381,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc. 宣布启动一项交换要约及同步的同意征求。此举旨在获得现有票据持有人的支持，以消除公司账面上超过1.2亿美元的债务。该策略意在优化资本结构，减轻财务负担。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136432627","title":"Gossamer Bio暂停三期Seranata研究在Ph-ILD患者中的招募，公司正评估Prosera结果影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1136432627","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136432627?lang=zh_cn&edition=full","pubTime":"2026-03-18 04:03","pubTimestamp":1773777791,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc.宣布，在评估Prosera试验结果对临床项目的影响期间，已暂停针对进行性肺纤维化间质性肺病（Ph-ILD）患者的三期Seranata研究的新患者招募工作。该决定旨在确保临床试验方案与最新数据保持科学一致性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168602592","title":"Gossamer Bio公布2025年第四季度及全年业绩，并披露公司最新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1168602592","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168602592?lang=zh_cn&edition=full","pubTime":"2026-03-18 04:02","pubTimestamp":1773777733,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc.近日正式发布了2025年第四季度及全年财务报告，同时向市场同步了企业运营的最新动态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618096272","title":"Gossamer Bio, Inc.盘中异动 早盘急速跳水5.29%报0.526美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618096272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618096272?lang=zh_cn&edition=full","pubTime":"2026-03-10 21:45","pubTimestamp":1773150343,"startTime":"0","endTime":"0","summary":"北京时间2026年03月10日21时45分，Gossamer Bio, Inc.股票出现异动，股价快速下挫5.29%。截至发稿，该股报0.526美元/股，成交量92.1547万股，换手率0.40%，振幅7.69%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.62%。其相关个股中，Mink Therapeutics, Inc.、Biorestorative Therapies, Inc.、Longeveron Inc.涨幅较大，Biorestorative Therapies, Inc.、Mink Therapeutics, Inc.、Scisparc Ltd.较为活跃，换手率分别为570.01%、229.95%、145.73%，振幅较大的相关个股有Acurx Pharmaceuticals, Inc.、Longeveron Inc.、Artelo Biosciences, Inc.，振幅分别为24.04%、24.02%、20.22%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310214543a6b5a442&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310214543a6b5a442&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614417820","title":"Gossamer Bio, Inc.盘中异动 早盘大幅下挫5.39%报0.393美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614417820","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614417820?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:35","pubTimestamp":1772030109,"startTime":"0","endTime":"0","summary":"北京时间2026年02月25日22时35分，Gossamer Bio, Inc.股票出现异动，股价大幅下挫5.39%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Moolec Science Sa C/Wts 30/01/2028、Surrozen Inc C/Wts 01/08/2031 、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Quince Therapeutics, Inc.、Ensysce Biosciences, Inc.、Edesa Biotech, Inc.较为活跃，换手率分别为157.96%、20.93%、14.22%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Larimar Therapeutics, Inc.、Onkure Therapeutics, Inc.，振幅分别为21.81%、15.45%、11.37%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022522351097a706ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022522351097a706ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133744072","title":"Leerink Partners下调Gossamer Bio评级至“与大盘持平”，目标价大幅削减至1美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133744072","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133744072?lang=zh_cn&edition=full","pubTime":"2026-02-24 20:06","pubTimestamp":1771934761,"startTime":"0","endTime":"0","summary":"投资机构Leerink Partners宣布，将生物制药公司Gossamer Bio Inc.的股票评级从“跑赢大盘”下调至“与大盘持平”。与此同时，该机构将其目标股价从6美元大幅调降至1美元，显示出对该公司近期前景的谨慎态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116218972","title":"Gossamer Bio股价盘前暴跌80%，其肺部疾病药物未能达到后期试验目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1116218972","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116218972?lang=zh_cn&edition=full","pubTime":"2026-02-23 21:40","pubTimestamp":1771854013,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc. 股价在盘前交易中遭遇断崖式下跌，跌幅高达80%，此前该公司宣布其针对肺部疾病研发的药物在关键后期试验中未能达到主要目标。\n这一重大挫折直接源于其核心候选药物的临床试验结果未达预期，导致市场对该公司的前景迅速转向悲观。投资者信心遭受重创，反映出生物科技领域高风险高回报的特性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131316037","title":"Gossamer Bio公布Seralutinib治疗肺动脉高压的III期Prosera研究顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1131316037","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131316037?lang=zh_cn&edition=full","pubTime":"2026-02-23 21:05","pubTimestamp":1771851937,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc. (股票代码：GOSS) 近日披露了其III期临床试验Prosera研究的顶线数据。该研究旨在评估候选药物Seralutinib在肺动脉高压患者中的疗效与安全性。\n这项关键性研究的结果标志着公司在肺动脉高压治疗领域的重要进展。顶线数据的公布为后续研发决策提供了关键依据，也将影响该药物的上市申请策略。\n肺动脉高压作为一种罕见且严重的疾病，目前仍存在未满足的临床需求。Seralutinib若最终获批，有望为患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106797748","title":"Gossamer Bio遗憾未能达到主要终点预设严格统计阈值 结果仍优于传统0.05显著性水平","url":"https://stock-news.laohu8.com/highlight/detail?id=1106797748","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106797748?lang=zh_cn&edition=full","pubTime":"2026-02-23 21:03","pubTimestamp":1771851797,"startTime":"0","endTime":"0","summary":"生物制药公司Gossamer Bio最新临床试验数据显示，其研究项目的主要终点指标虽以微小差距未达到预设的严格统计阈值，但实验结果依然突破了传统统计学中0.05的显著性水平门槛。这一结果既反映出研究设计的前瞻性，也凸显出药物开发过程中统计功效与临床意义之间的复杂平衡。\n尽管未能完全满足预设的严苛标准令研发团队感到遗憾，但跨越传统P值界限的成果仍为后续研究提供了重要数据支撑。该统计结果暗示治疗趋势的存在，为探索更精准的患者亚群分析及优化临床试验方案创造了空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","GOSS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518027458","title":"Gossamer Bio, Inc.盘中异动 早盘急速下跌5.37%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518027458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518027458?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:24","pubTimestamp":1741620245,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时24分，Gossamer Bio, Inc.股票出现波动，股价快速下跌5.37%。截至发稿，该股报1.15美元/股，成交量34.5502万股，换手率0.15%，振幅6.20%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。其相关个股中，Aeon Biopharma, Inc.、Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3606.98%、1130.61%、802.76%，振幅较大的相关个股有Aeon Biopharma, Inc.、Scisparc Ltd.、Dogwood Therapeutics, Inc.，振幅分别为51.05%、49.87%、41.36%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023240596404fff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023240596404fff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516677355","title":"Gossamer Bio, Inc.盘中异动 股价大跌5.08%报1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677355?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098771,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Gossamer Bio, Inc.股票出现异动，股价急速下跌5.08%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1054.48%、1052.09%、415.30%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Adma Biologics Inc、Amylyx Pharmaceuticals, Inc.，振幅分别为23.30%、12.57%、11.00%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223251a25f0502&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223251a25f0502&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514373339","title":"Gossamer Bio, Inc.盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514373339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514373339?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:32","pubTimestamp":1740753144,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时32分，Gossamer Bio, Inc.股票出现异动，股价快速下挫5.04%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为483.74%、242.14%、62.32%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Enveric Biosciences, Inc.、Abcellera Biologics Inc.，振幅分别为31.14%、9.91%、8.73%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223224a2580166&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223224a2580166&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514867417","title":"Gossamer Bio, Inc.盘中异动 股价大涨5.16%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514867417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514867417?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:52","pubTimestamp":1740603120,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时52分，Gossamer Bio, Inc.股票出现波动，股价急速拉升5.16%。截至发稿，该股报1.33美元/股，成交量147.224万股，换手率0.65%，振幅7.08%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6933.13%、367.50%、268.58%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为194.07%、81.11%、70.39%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227045200a2554a83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227045200a2554a83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514015884","title":"Gossamer Bio, Inc.盘中异动 早盘股价大跌5.13%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514015884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514015884?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:11","pubTimestamp":1740496281,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时11分，Gossamer Bio, Inc.股票出现异动，股价快速下跌5.13%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 、Lava Therapeutics N.V.涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1039.44%、582.78%、531.65%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Gri Bio, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为58.82%、56.51%、43.70%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231122989255e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231122989255e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","GOSS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513717722","title":"Gossamer Bio, Inc.盘中异动 急速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513717722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513717722?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:32","pubTimestamp":1740407549,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时32分，Gossamer Bio, Inc.股票出现波动，股价急速跳水5.00%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029、Nutriband Inc C/Wts 涨幅较大，Aditxt, Inc.、Biodexa Pharmaceuticals Plc、Acurx Pharmaceuticals, Inc.较为活跃，换手率分别为40.29%、24.06%、17.71%，振幅较大的相关个股有Gossamer Bio, Inc.、Summit Therapeutics Inc.、Estrella Immunopharma, Inc.，振幅分别为14.69%、12.61%、12.38%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242232299890f5bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242232299890f5bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513152294","title":"Gossamer Bio, Inc.盘中异动 大幅下挫5.23%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513152294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513152294?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:39","pubTimestamp":1740152363,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时39分，Gossamer Bio, Inc.股票出现波动，股价急速下挫5.23%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech Inc C/Wts 31/05/2028、Nkgen Biotech, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃，换手率分别为177.95%、113.34%、35.32%，振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为57.50%、48.19%、36.69%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221233923988dedd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221233923988dedd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gossamerbio.com;ir.gossamerbio.com","stockEarnings":[{"period":"1week","weight":0.2463},{"period":"1month","weight":0.0107},{"period":"3month","weight":-0.5416},{"period":"6month","weight":-0.9257},{"period":"1year","weight":-0.9169},{"period":"ytd","weight":-0.9453}],"compareEarnings":[{"period":"1week","weight":0.011},{"period":"1month","weight":0.0017},{"period":"3month","weight":0.0366},{"period":"6month","weight":0.0796},{"period":"1year","weight":0.1819},{"period":"ytd","weight":0.0955}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Gossamer Bio, Inc.于2015年10月26日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于开发和商业化seralutinib，用于治疗肺动脉高压，包括肺动脉高压和与间质性肺病相关的肺动脉高压。它由一支在领先生物制药公司拥有丰富经验的管理团队领导。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.040994},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.054406},{"month":3,"riseRate":0,"avgChangeRate":-0.132047},{"month":4,"riseRate":0.375,"avgChangeRate":-0.066505},{"month":5,"riseRate":0.5,"avgChangeRate":-0.050109},{"month":6,"riseRate":0.625,"avgChangeRate":0.083834},{"month":7,"riseRate":0.625,"avgChangeRate":0.11719},{"month":8,"riseRate":0.714286,"avgChangeRate":0.097398},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.027644},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.109871},{"month":11,"riseRate":0.571429,"avgChangeRate":0.095879},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.08654}],"exchange":"NASDAQ","name":"Gossamer Bio Inc.","nameEN":"Gossamer Bio Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Gossamer Bio Inc.(GOSS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Gossamer Bio Inc.(GOSS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Gossamer Bio Inc.,GOSS,Gossamer Bio Inc.股票,Gossamer Bio Inc.股票老虎,Gossamer Bio Inc.股票老虎国际,Gossamer Bio Inc.行情,Gossamer Bio Inc.股票行情,Gossamer Bio Inc.股价,Gossamer Bio Inc.股市,Gossamer Bio Inc.股票价格,Gossamer Bio Inc.股票交易,Gossamer Bio Inc.股票购买,Gossamer Bio Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Gossamer Bio Inc.(GOSS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Gossamer Bio Inc.(GOSS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}